Michael-Rock Goldsmith
Co-founder & Chief Innovation Scientist @Congruence Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Co-founder & Chief Innovation Scientist @Congruence Therapeutics
Raleigh-Durham-Chapel Hill, NC, US
Congruence Therapeutics is a biotechnology company using a unique computational platform to develop pharmacological stabilizers for rare diseases.
EDUCATION
Duke University
Ph.D., Computational Chemistry
Concordia University
B.Sc. Honors - CO-OP, Chemistry
Marianopolis College
DEC, Health Sciences
Lower Canada College
Secondary School Diploma
SKILLS
ABOUT MICHAEL-ROCK GOLDSMITH
Specialties: docking, QSAR, conformational analysis, vHTS, computational/predictive toxicology, product engineering, formulation and kinetic optimization/design, scientific computing, ecological epidemiology, passive interrogation, computational discovery chemistry for biologically active small molecules
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.